GLP-1 agonists also showed similar protective effects for ocular hypertension, with a 56% risk reduction at one year, 57% at two years and 49% at three years
Before she lost weight, she says, that never happened
Storage Each package is opened and checked to confirm its contents
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
SSRIs are one of the most common classes of drugs due to the prevalence of depression and anxiety, as well as related serotonin disorders
Overall, compared with the large and growing amount of pre-clinical and mechanistic evidence highlighting the reward-modulating and thus potentially anti-addictive properties of GLP-1RAs, only a few studies have investigated thus far the potential use of these medications in clinical populations with alcohol- or other substance-use disorders